- Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience
-
Douangprachanh S, Joo HJ, Park HM, Han N, Jang HY, Koh YH, Kim TH, Han SS, Park SJ, Lee WJ, Woo SM, Chun JW
- KMID: 2535987
- Korean J Intern Med.
- 2022 Nov;37(6):1216-1222.
- doi: 10.3904/kjim.2022.100
Background/Aims: The combination of capecitabine and temozolomide (CAPTEM) is one of the treatment options for metastatic pancreatic neuroendocrine neoplasms (pNENs). This study aims to evaluate the efficacy of CAPTEM in... -
- CITED
-
- Close
- SHARE
-
- Close
